These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
563 related items for PubMed ID: 17294560
41. Final regulations for the nutrition labeling of raw fruits, vegetables, and fish. Pennington JA, Wilkening VL. J Am Diet Assoc; 1997 Nov; 97(11):1299-305. PubMed ID: 9366869 [Abstract] [Full Text] [Related]
42. Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule. Food and Drug Administration, HHS. Fed Regist; 2001 Jun 06; 66(109):30311-3. PubMed ID: 11724074 [Abstract] [Full Text] [Related]
43. Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Food and Drug Administration, HHS. Interim final rule. Fed Regist; 2000 Sep 08; 65(175):54686-739. PubMed ID: 11503640 [Abstract] [Full Text] [Related]
47. Nutrition marketing on food labels. Colby SE, Johnson L, Scheett A, Hoverson B. J Nutr Educ Behav; 2010 Sep 08; 42(2):92-8. PubMed ID: 20096635 [Abstract] [Full Text] [Related]
48. Nutrition and health claims: the role of food composition data. Buttriss JL, Benelam B. Eur J Clin Nutr; 2010 Nov 08; 64 Suppl 3():S8-13. PubMed ID: 21045856 [Abstract] [Full Text] [Related]
50. Health claims on food labels. Tollefson L. Mil Med; 1994 Mar 08; 159(3):213-7. PubMed ID: 8041466 [Abstract] [Full Text] [Related]
51. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule. Food and Drug Administration, HHS. Fed Regist; 2010 Mar 19; 75(53):13225-32. PubMed ID: 20383919 [Abstract] [Full Text] [Related]
52. New Food and Drug Administration health claim requirements get mixed response. Brown D. J Am Diet Assoc; 2005 Jan 19; 105(1):19-20. PubMed ID: 15635338 [No Abstract] [Full Text] [Related]
55. Labeling of trans fatty acid content in food, regulations and limits-the FDA view. Moss J. Atheroscler Suppl; 2006 May 19; 7(2):57-9. PubMed ID: 16713387 [Abstract] [Full Text] [Related]
58. The "natural" aversion: the FDA's reluctance to define a leading food-industry marketing claim, and the pressing need for a workable rule. Farris AL. Food Drug Law J; 2010 May 19; 65(2):403-24, iv. PubMed ID: 24475548 [Abstract] [Full Text] [Related]
59. Major issues in marketing regulation. Pines WL. Food Drug Law J; 1997 May 19; 52(3):297-302. PubMed ID: 10343028 [No Abstract] [Full Text] [Related]
60. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule. Food and Drug Administration, HHS. Fed Regist; 2002 Jan 23; 67(15):3060-76. PubMed ID: 11820251 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]